Results 41 to 50 of about 3,769,586 (361)

Catch of the Day: New Serum Amyloid A (SAA) Antibody Is a Valuable Tool to Study Fish Health in Salmonids

open access: yesCells, 2023
Serum amyloid A (SAA) proteins belong to a family of acute-phase reactants, playing an integral role in defending the organism from pathological damage.
Ralfs Buks   +6 more
doaj   +1 more source

Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III).

open access: yesJournal of Clinical Endocrinology and Metabolism, 2002
NHANES III measured serum TSH, total serum T(4), antithyroperoxidase (TPOAb), and antithyroglobulin (TgAb) antibodies from a sample of 17,353 people aged > or =12 yr representing the geographic and ethnic distribution of the U.S. population.
J. Hollowell   +6 more
semanticscholar   +1 more source

Prospective mapping of viral mutations that escape antibodies used to treat COVID-19

open access: yesbioRxiv, 2020
Antibodies are becoming a frontline therapy for SARS-CoV-2, but the risk of viral evolutionary escape remains unclear. Here we map how all mutations to SARS-CoV-2’s receptor-binding domain (RBD) affect binding by the antibodies in Regeneron’s REGN-COV2 ...
Tyler N. Starr   +7 more
semanticscholar   +1 more source

Acknowledgement to Reviewers of Antibodies in 2017

open access: yesAntibodies, 2018
Peer review is an essential part in the publication process, ensuring that Antibodies maintains high quality standards for its published papers.[...]
Antibodies Editorial Office
doaj   +1 more source

The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients

open access: yesScience immunology, 2020
The serum level of RBD-binding antibodies correlates with SARS-CoV-2 neutralization and can be used for population-level surveillance. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that first emerged in late 2019 is responsible for a ...
L. Premkumar   +23 more
semanticscholar   +1 more source

Broad Epitope Coverage of Therapeutic Multi-Antibody Combinations Targeting SARS-CoV-2 Boosts In Vivo Protection and Neutralization Potency to Corner an Immune-Evading Virus

open access: yesBiomedicines
Therapeutic antibodies (Abs) which act on a broader range of epitopes may provide more durable protection against the genetic drift of a target, typical of viruses or tumors.
Ilse Roodink   +20 more
doaj   +1 more source

Acknowledgement to Reviewers of Antibodies in 2013

open access: yesAntibodies, 2014
The editors of Antibodies would like to express their sincere gratitude to the following reviewers for assessing manuscripts in 2013.
Antibodies Editorial Office
doaj   +1 more source

Identification, Efficacy, and Stability Evaluation of Succinimide Modification With a High Abundance in the Framework Region of Golimumab

open access: yesFrontiers in Chemistry, 2022
Succinimide (Asu) is the intermediate for asparagine deamidation in therapeutic proteins, and it can be readily hydrolyzed to form aspartate and iso-aspartate residues. Moreover, Asu plays an important role in the protein degradation pathways, asparagine
Tao Liu   +22 more
doaj   +1 more source

Antibodies in Infants Born to Mothers With COVID-19 Pneumonia.

open access: yesJournal of the American Medical Association (JAMA), 2020
This study describes results of IgM and IgG antibody testing from throat swabs of newborns born to mothers with COVID-19 pneumonia.
Hui Zeng   +6 more
semanticscholar   +1 more source

Encephalitis with mGluR5 antibodies [PDF]

open access: yesNeurology, 2018
To report the clinical features of 11 patients with metabotropic glutamate receptor 5 (mGluR5) antibody-associated encephalitis, immunoglobulin G (IgG) subclass, and effects of the antibodies on neuronal mGluR5 clusters.Clinical information was retrospectively obtained from referring physicians.
Spatola, Marianna   +15 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy